Boardwalk pipelines to acquire Spire Marketing in strategic natural gas expansion
Boardwalk Pipelines (NYSE:SR) announced today that it has entered into a definitive agreement to acquire Spire Marketing from Spire.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Boardwalk Pipelines (NYSE:SR) announced today that it has entered into a definitive agreement to acquire Spire Marketing from Spire.
United Therapeutics (NASDAQ:UTHR), a public benefit corporation, today announced that its pivotal TETON-1 study evaluating nebulized Tyvaso® (treprostinil) for the treatment of idiopathic pulmonary fibrosis (IPF) met its primary efficacy endpoint.
Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biotechnology company pioneering precision medicines for brain diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
GSK (NYSE:GSK) today announced that China’s National Medical Products Administration (NMPA) has granted approval for Exdensur (depemokimab) as an add-on maintenance treatment for severe asthma characterized by an eosinophilic phenotype.
Sysco (NYSE:SYY), North America’s largest foodservice distributor, announced an agreement to acquire Jetro Restaurant Depot, a leading cash-and-carry wholesaler serving independent restaurants and foodservice operators, for approximately $29.1 billion in a combination of cash and stock.
Zymeworks (NASDAQ:ZYME), a clinical-stage biotechnology company developing multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191 for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).
Leidos (NYSE:LDOS), a Fortune 500 innovation leader in defense, aviation, and information technology, announced today the successful completion of its acquisition of ENTRUST Solutions Group for approximately $2.4 billion.
IDEAYA Biosciences (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the first-patient-in (FPI) for its Phase 1 clinical trial evaluating the combination of IDE849 and IDE161.
NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches, today announced promising initial data from the Phase 2 CONVERGE study evaluating its lead candidate, JNJ-1900 (NBTXR3), in patients with stage 3 inoperable non-small cell lung cancer (NSCLC).
Bitdeer Technologies Group (NASDAQ:BTDR), a global leader in advanced computing and blockchain infrastructure, announced today that its subsidiary, Tydal Data Center AS (TDC), has officially engaged Data Center Installations AS (DCI) to develop a state-of-the-art 180 MW artificial intelligence data center in Tydal, Norway.
Palantir Technologies (NASDAQ:PLTR) today announced a five-year renewal and expansion of its strategic partnership with Stellantis (NYSE:STLA).
Rio Tinto Group (NYSE:RIO), the world’s leading iron ore producer, announced Monday that it has resumed ship loading at the majority of its Pilbara port terminals following a temporary suspension caused by Tropical Cyclone Narelle.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade